Intermittent real-time continuous glucose monitoring for three months improved and sustained glycemic control better than self-monitoring in patients with type 2 diabetes who were not on prandial insulin treatment, researchers reported in Diabetes Care. Researchers noted a greater decline in hemoglobin A1C levels, without the need for intensified medications, in those who had RT-CGM compared with those in the self-monitoring group.
Study links continuous glucose monitoring to better glycemic control
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Director of Clinical Research||
Regenesis Biomedical, Inc.